Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.

Vasc Health Risk Manag · 2009 · PMC2672468 · PMID 19436679

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an interesting trendno p-value reported

Analysis of the secondary endpoints of AMADEO trial brings forth an interesting trend.

also in 1,783 other papers

failed to reach significanceno p-value reported

The difference in secondary end points of serum creatinine, eGFR, serum aldosterone and CRP failed to reach significance ( Table 3B ).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.